[Plasma and pancreatic levels of diphenylhydantoin and their relation to protection from chemical diabetes induced alloxan in mice].
作者信息
Espósito Avella M, Martínez M, Vergara G
出版信息
Rev Med Panama. 1981 Sep;6(3):278-88.
PMID:7036239
Abstract
摘要
相似文献
1
[Plasma and pancreatic levels of diphenylhydantoin and their relation to protection from chemical diabetes induced alloxan in mice].
Rev Med Panama. 1981 Sep;6(3):278-88.
2
Inhibitory effect of diphenylhydantoin on the diabetogenic action of alloxan in the mouse.
Diabetes. 1972 Feb;21(2):80-3. doi: 10.2337/diab.21.2.80.
3
Studies on the protective effect of diphenylhydantoin against alloxan diabetes in mice.
Proc Soc Exp Biol Med. 1973 Jan;142(1):82-5. doi: 10.3181/00379727-142-36963.
4
[Cytoprotective effect of prostaglandin E2 on pancreatic islet beta-cells of alloxan-induced diabetic rats].
Sheng Li Xue Bao. 1986 Apr;38(2):191-201.
5
Protection against alloxan diabetes by low-dose 60Co gamma irradiation before alloxan administration.
Physiol Chem Phys Med NMR. 1995;27(3):149-59.
6
Reduction in the diabetogenic effect of alloxan in mice by treatment with the antineoplastic agent ICRF-187.
Res Commun Chem Pathol Pharmacol. 1981 Sep;33(3):509-23.
7
Beta cell protection to alloxan necrosis by anomers of D-glucose.
Science. 1974 Feb 1;183(4123):424. doi: 10.1126/science.183.4123.424.
8
9
[Nickel chloride and alloxan. I. Determination of glucose, insulin and superoxide dismutase in blood and pancreas of rats].
Acta Physiol Pharmacol Latinoam. 1987;37(3):377-93.
10
Differential target molecules for toxicity induced by streptozotocin and alloxan in pancreatic islets of mice in vitro.
Exp Clin Endocrinol Diabetes. 2004 Jan;112(1):29-37. doi: 10.1055/s-2004-815724.
Zotero 插件